# Efficacy of Azelastine and Mometasone Irrigation in Comparison to Nasal Sprays in Patients With Chronic Rhinitis

> **NCT05626621** · PHASE4 · RECRUITING · sponsor: **Endeavor Health** · enrollment: 81 (estimated)

## Conditions studied

- Chronic Rhinitis

## Interventions

- **DRUG:** Azelastine (137 mcg/spray) Nasal Spray and Mometasone (50 mcg/spray) Nasal Spray
- **DRUG:** Mometasone Nasal Irrigation (1 mg capsule)
- **DRUG:** Mometasone (1 mg) and Azelastine (1 mg) Nasal Irrigation

## Key facts

- **NCT ID:** NCT05626621
- **Lead sponsor:** Endeavor Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-23
- **Primary completion:** 2025-08
- **Final completion:** 2026-08
- **Target enrollment:** 81 (ESTIMATED)
- **Last updated:** 2023-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05626621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05626621, "Efficacy of Azelastine and Mometasone Irrigation in Comparison to Nasal Sprays in Patients With Chronic Rhinitis". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05626621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*